Updates

Brooks Laboratories Limited announced its board has approved the sale of 51,220 equity shares in Brooks Steriscience Limited. The shares will be sold to Steriscience Specialities Private Limited for a cash consideration of ₹20,760 per share. This transaction aggregates to approximately ₹106.33 crore, pending customary documentation and regulatory requirements. For investors, this represents a significant divestment by Brooks Laboratories, generating substantial cash flow which could be used for other strategic initiatives or strengthening its financial position.